Olaf Ritzeler

USPTO Granted Patents = 18 (Patent Applications = 3)

CIPO Patents = 3

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 223(Granted Patents)

Location History:

Bad Soden, DE (2007 - 2014)
Franfurt am Main, DE (2015)
Frankfurt-am-Main, DE (2002 - 2023)

Company Filing History:

Sanofi-a Ventis Deutschland Gmbh

patents

2 out of 330

Aventis Pharma Deutschland, Gmbh

patents

Years Active: 2002-2025

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12275733 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2025-04-14),

2. 11827633 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2023-11-28),

3. 11130755 - Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders (2021-09-28),

4. 9675606 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors (2017-06-13),

5. 9440941 - Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals (2016-09-13),

6. 9126972 - 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors (2015-09-08),

7. 9067918 - Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide (2015-06-30),

8. 8912224 - Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals (2014-12-16),

9. 8809358 - Use of IκB-kinase inhibitors in pain therapy (2014-08-19),

10. 8778955 - Indole derivatives or benzimidazole derivatives for modulating IkB kinase (2014-07-15),

11. 8153637 - Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereof (2012-04-10),

12. 7462638 - Use of IκB-kinase inhibitors in pain therapy (2008-12-09),

13. 7348336 - Substituted β-carbolines (2008-03-25),

14. 7342029 - Substituted indoles (2008-03-11),

15. 7285560 - Indole derivatives or benzimidazole derivatives for modulating IκB kinase (2007-10-23),

Title: Olaf Ritzeler: A Trailblazer in Innovation

Introduction:

Olaf Ritzeler, a passionate inventor based in Frankfurt am Main, Germany, has made a significant impact in the world of inventions with his relentless drive to create a better future through technology. With 17 patents to his name, he has cemented his legacy as a true trailblazer in the field of innovation.

Latest Patents:

One of Olaf Ritzeler's latest patents is centered around "Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders." This invention focuses on compounds that stimulate chondrogenesis and cartilage matrix synthesis, offering potential treatment options for cartilage disorders such as osteoarthritis. The patent also includes processes for the synthesis of these compounds, their pharmaceutical uses, and compositions.

Career Highlights:

Throughout his career, Olaf Ritzeler has been associated with renowned companies such as Sanofi and Sanofi-a Ventis Deutschland GmbH, where he has contributed significantly to the field of pharmaceuticals and healthcare. His innovative approach to solving medical challenges has led to the development of groundbreaking inventions that have the potential to improve the quality of life for many.

Collaborations:

Olaf Ritzeler has collaborated with esteemed professionals in the industry, including Gerhard Jaehne and Alfredo C Castro. These collaborations have been instrumental in bringing his inventions to life and expanding the scope of his innovative projects. Working alongside talented individuals has further fueled his passion for innovation and has resulted in successful partnerships that have pushed the boundaries of technological advancements.

Conclusion:

Olaf Ritzeler's dedication to innovation, coupled with his drive to make a meaningful impact on society through his inventions, sets him apart as a visionary in the world of patents and inventions. His contributions to the field of healthcare and pharmaceuticals are commendable, and his legacy as a trailblazer in innovation is sure to inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.